Nadendla Eswar Kumar, Tweedell Rebecca E, Kasof Gary, Kanneganti Thirumala-Devi
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Cell Signaling Technology, Danvers, MA, USA.
Cell Discov. 2025 May 5;11(1):42. doi: 10.1038/s41421-025-00791-3.
Caspases are critical regulators of cell death, development, innate immunity, host defense, and disease. Upon detection of pathogens, damage-associated molecular patterns, cytokines, or other homeostatic disruptions, innate immune sensors, such as NLRs, activate caspases to initiate distinct regulated cell death pathways, including non-lytic (apoptosis) and innate immune lytic (pyroptosis and PANoptosis) pathways. These cell death pathways are driven by specific caspases and distinguished by their unique molecular mechanisms, supramolecular complexes, and enzymatic properties. Traditionally, caspases are classified as either apoptotic (caspase-2, -3, -6, -7, -8, -9, and -10) or inflammatory (caspase-1, -4, -5, and -11). However, extensive data from the past decades have shown that apoptotic caspases can also drive lytic inflammatory cell death downstream of innate immune sensing and inflammatory responses, such as in the case of caspase-3, -6, -7, and -8. Therefore, more inclusive classification systems based on function, substrate specificity, or the presence of pro-domains have been proposed to better reflect the multifaceted roles of caspases. In this review, we categorize caspases into CARD-, DED-, and short/no pro-domain-containing groups and examine their critical functions in innate immunity and cell death, along with their structural and molecular mechanisms, including active site/exosite properties and substrates. Additionally, we highlight the emerging roles of caspases in cellular homeostasis and therapeutic targeting. Given the clinical relevance of caspases across multiple diseases, improved understanding of these proteins and their structure-function relationships is critical for developing effective treatment strategies.
半胱天冬酶是细胞死亡、发育、固有免疫、宿主防御和疾病的关键调节因子。一旦检测到病原体、损伤相关分子模式、细胞因子或其他体内稳态破坏,固有免疫传感器,如NLRs,就会激活半胱天冬酶,以启动不同的程序性细胞死亡途径,包括非裂解性(凋亡)和固有免疫裂解性(细胞焦亡和PANoptosis)途径。这些细胞死亡途径由特定的半胱天冬酶驱动,并以其独特的分子机制、超分子复合物和酶特性加以区分。传统上,半胱天冬酶分为凋亡性(半胱天冬酶-2、-3、-6、-7、-8、-9和-10)或炎性(半胱天冬酶-1、-4、-5和-11)。然而,过去几十年的大量数据表明,凋亡性半胱天冬酶也可在固有免疫传感和炎症反应下游驱动裂解性炎性细胞死亡,如半胱天冬酶-3、-6、-7和-8的情况。因此,已提出基于功能、底物特异性或前结构域的存在的更具包容性的分类系统,以更好地反映半胱天冬酶的多方面作用。在本综述中,我们将半胱天冬酶分为含CARD、含DED和含短/无前结构域的组,并研究它们在固有免疫和细胞死亡中的关键功能,以及它们的结构和分子机制,包括活性位点/别构位点特性和底物。此外,我们强调了半胱天冬酶在细胞内稳态和治疗靶向中的新作用。鉴于半胱天冬酶在多种疾病中的临床相关性,更好地理解这些蛋白质及其结构-功能关系对于制定有效的治疗策略至关重要。